Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 584.00
-2.00 (-0.34%)
Dec 19, 2025, 3:30 PM KST
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 115.38 billion as of December 19, 2025. Its market cap has decreased by -21.61% in one year.
Market Cap
115.38B
Enterprise Value
331.42B
Revenue
74.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
584.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 115.38B, an increase of 3,527.73%. That is a compound annual growth rate of 12.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 115.38B | -11.78% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | 524.12B | 60.07% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.22T |
| Celltrion | 40.37T |
| ALTEOGEN | 23.96T |
| ABL Bio | 10.50T |
| SK Biopharmaceuticals | 10.09T |
| Yuhan | 8.64T |
| LigaChem Biosciences | 6.25T |
| HLB Co., Ltd. | 6.10T |